Office of Biostatistics MATLAB Software

The Food and Drug Administration is forecasting a contract opportunity for software acquisition aimed at supporting simulations and numerical solutions for complex systems, specifically within pharmacokinetic applications. The software in question is MATLAB, a tool widely used for modeling, simulation, and computation, which will be utilized by the Office of Biostatistics to enhance their analytical capabilities. This contract falls under NAICS code 519130, relating to internet publishing and broadcasting and web search portals, indicating the technical and software development nature of the requirement. While the posting date is March 11, 2026, specific details such as solicitation number, set-aside type, and the exact place of performance remain unspecified. The agency’s point of contact includes the Cder Acquisition Liaison for program-related communication, with a contracting officer yet to be determined. This acquisition is part of the FDA’s initiative to equip its biostatistics office with advanced computational tools necessary for precise and efficient analysis of pharmacokinetic data, crucial for drug development and evaluation processes.